Fig. 3
From: Cerumenogram as an assay for the metabolic diagnosis of precancer, cancer, and cancer remission
(A) Group test: metaplasia (n = 3), dysplasia (n = 3), and benign tumors (n = 11). (B) Sample prediction table showing the sample labels, predicted class by the Cerumenogram assay (N-OR = Oncological Risk-free, Y-OR = Oncological Risk), diagnostic category (MP = Metaplasia, DP = Dysplasia, BT-C = Benign Tumor), and the clinical diagnostic description of each volunteer.
